Short Interest in Dalrada Financial Co. (OTCMKTS:DFCO) Expands By 25.3%

Dalrada Financial Co. (OTCMKTS:DFCOGet Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 20,800 shares, a growth of 25.3% from the November 30th total of 16,600 shares. Based on an average daily trading volume, of 231,900 shares, the short-interest ratio is presently 0.1 days.

Dalrada Financial Trading Up 5.1 %

Shares of Dalrada Financial stock opened at $0.06 on Tuesday. The company’s 50-day moving average price is $0.07 and its 200-day moving average price is $0.12. The company has a current ratio of 1.50, a quick ratio of 1.24 and a debt-to-equity ratio of 0.33. Dalrada Financial has a 12-month low of $0.04 and a 12-month high of $0.24. The company has a market cap of $7.45 million, a price-to-earnings ratio of -0.27 and a beta of 1.26.

Dalrada Financial Company Profile

(Get Free Report)

Dalrada Financial Corporation, together with its subsidiaries, operates as a technology and manufacturing company. It operates through Genefic, Dalrada Energy Services, Dalrada Precision Manufacturing, and Dalrada Technologies divisions. The Genefic division processes molecular diagnostic and antibody tests to support the diagnosis of COVID-19 and the detection of immune response to the virus; markets and sells traditional biologics and human cells, tissues, and cellular and tissue-based products; and provides prescription management, education, nursing, and total health solutions; distributes alcohol-free hand sanitizers, surface cleaners, laundry aides, antimicrobial solutions, electrostatic sprayers, face masks, gloves, and kits, as well as dispensers, stands, and ease of use packaging for the end consumers.

See Also

Receive News & Ratings for Dalrada Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dalrada Financial and related companies with MarketBeat.com's FREE daily email newsletter.